Charles River Laboratories International Inc (CRL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Charles River Laboratories International inc   (NYSE: CRL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Charles River Laboratories International Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 27 2026, Charles River Laboratories International Inc has not recorded any inventories.
Visit Charles River Laboratories International Inc Balance sheet

Within Healthcare sector 69 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 432 in the first quarter 2026, to 519.

CRL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Charles River Laboratories International Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRL Inventory Turnover Ratio (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 27 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Inventory Growth 23.86 % 23.98 % 7.38 % -10.01 % -19.93 %
Y / Y Cost of Sales Growth - 5.45 % 2047.49 % -13.33 % -13.02 %
Inventory Turnover Ratio (TTM) - 7.56 7.9 6.12 6.25
CRL's Total Ranking # 519 # 432 # 359 # 320 # 410
Average inventory processing period - 48 46 60 58
Seq. Inventory Growth -3.74 % 20.27 % -1.14 % 8.23 % -3.66 %
Seq. Cost of Sales Growth - 5.02 % 1.25 % -2.09 % 1.29 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 70
Overall Market # 519

Inventory Turnover Ratio Statistics
High Average Low
10.76 7.84 5.39
(Sep 28 2013)   (Jun 27 2026)



CRL Company Profile >> Back to CRL Efficiency Comparisons >> Compare CRL Inventory Turnover Ratio to its Competitors

Financial Statements
Charles River Laboratories International Inc 's Inventories $ 346 Millions Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Cost of Revenues TTM $ 1,761 Millions Visit CRL's Income Statement
What are CRL's Sales? Visit CRL's Sales by Segment

Other Inventory Turnover Ratios
Charles River Laboratories International Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CRL's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CRL's Competitors
Inventory Turnover Ratio for CRL's Suppliers
Inventory Turnover Ratio for CRL's Customers

You may also want to know
CRL's Sales Growth Rates CRL's Pe Price to earnings ratio CRL's Receivables Turnover Ratio CRL's Stock Quote
CRL's Net Income Growth Rates CRL's Ps Price to Sales ratio CRL's Sales per Employee CRL's Asset Turnover Ratio
CRL's Net Margin CRL's Pb Price to Book ratio CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 27 2026 Inventories at quarter ending Jun 27 2026
Edap Tms Sa  12.79 $ 62.351  Millions$ 5  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions

Date modified: 2026-09-01T19:51:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.